1.47
+0.01(+0.68%)
Currency In USD
| Previous Close | 1.46 |
| Open | 1.46 |
| Day High | 1.54 |
| Day Low | 1.41 |
| 52-Week High | 21.09 |
| 52-Week Low | 0.26 |
| Volume | 1.22M |
| Average Volume | 3.54M |
| Market Cap | 257.33M |
| PE | 4.2 |
| EPS | 0.35 |
| Moving Average 50 Days | 1.23 |
| Moving Average 200 Days | 1 |
| Change | 0.01 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $147.89 as of February 05, 2025 at a share price of $1.47. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $142.58 as of February 05, 2025 at a share price of $1.47.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
GlobeNewswire Inc.
Jan 28, 2025 8:49 PM GMT
The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections.Tevogen Bio may also utilize the grant funding to further expand its artificial intelligence effort.This grant is in addition to t
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
GlobeNewswire Inc.
Jan 27, 2025 7:24 PM GMT
WARREN, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, Chairman and founding CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech, congratulates Lynne Patton on bei
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
GlobeNewswire Inc.
Jan 24, 2025 10:34 PM GMT
This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification. Tevogen Bio is also proactively investigat